Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Virtual Biopsy Market Growth Evolved From 2024 To 2025, And What’s Ahead?#_x000D_

There has been rapid growth in the market size of virtual biopsies in recent years. Rising from a value of $0.63 billion in 2024, it is forecasted to increase to $0.71 billion in 2025, with a compound annual growth rate (CAGR) of 11.4%. The growth during the historic period is linked to the escalating demand for non-invasive diagnostic techniques, a heightened preference for early detection of diseases, improving efficiency of medical imaging software, the rising comfort and convenience for patients, and the increase in the availability of telemedicine services._x000D_

_x000D_

In the next several years, the size of the virtual biopsy market is projected to grow rapidly, reaching $1.11 billion in 2029 with a compound annual growth rate (CAGR) of 11.8%. This growth momentum during the forecast period is likely to be fuelled by factors such as a greater emphasis on cost-efficient healthcare solutions, increasing preventative healthcare initiatives, a surge in demand for customised medicine, a higher need for minimally invasive procedures in cancer treatments, and the rising relevance of precision oncology. Additionally, key trends for this period include the advancement in imaging sensors, the development of multimodal biopsy methods, the adoption of robotics for enhanced precision, advancement in non-invasive biomarker detection techniques, and the incorporation of three-dimensional (3D) visualisation instruments._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=24424&type=smp_x000D_

_x000D_

#What Are the Core Market Drivers Propelling Growth in the Virtual Biopsy Industry?#_x000D_

The increasing occurrence of cancer-related conditions is projected to fuel the expansion of the virtual biopsy market. Such health conditions involve abnormal cell proliferation and spread throughout the body, and their growing occurrence is mostly due to lifestyle alterations such as bad eating habits, lack of physical activity, tobacco consumption, and increased exposure to environmental pollutants. Virtual biopsies enhance cancer condition diagnosis and tracking by offering real-time, non-invasive imaging insights. These reduce the need for conventional tissue biopsies and heighten precision and patient safety. As an example, the Australian Institute of Health and Welfare, an agency run by the Australian government, reported that cancer diagnoses in Australia grew to 160,570 cases in 2022, a rise of 3,789 cases from 156,781 in 2021, in July 2024. Consequently, the escalating rate of cancer-related conditions is propelling the virtual biopsy market’s development._x000D_

_x000D_

#How Is the Virtual Biopsy Market Segmented?#_x000D_

The virtual biopsymarket covered in this report is segmented – _x000D_

_x000D_

1) By Target Thrapeutic Areas: Oncological Disorders, Neurological Disorders, Cardiovascular Disorders, Ophthalmological Disorders, Endocrine Disorders, Gastrointestinal Disorders, Other Target Therapeutic Areas_x000D_

2) By Cancer Targeted: Solid Malignancies, Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Cancer, Other Cancer Targeteds_x000D_

3) By Imaging Technologies: Magnetic Resonance Imaging, Computed Tomography, X-Ray, Ultrasound, Other Imaging Technologies_x000D_

4) By End Users: Hospitals And Clinics, Research Institutes And Diagnostic Centers, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Oncological Disorders: Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Liver Cancer, Brain Tumors, Other Cancers_x000D_

2) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Brain Injuries, Stroke, Other Neurological Conditions_x000D_

3) By Cardiovascular Disorders: Coronary Artery Disease, Heart Failure, Arrhythmias, Aortic Aneurysm, Valvular Heart Disease, Myocardial Infarction, Other Cardiovascular Conditions_x000D_

4) By Ophthalmological Disorders: Age-Related Macular Degeneration, Diabetic Retinopathy, Glaucoma, Retinal Vein Occlusion, Cataracts, Other Eye Disorders_x000D_

5) By Endocrine Disorders: Diabetes Mellitus, Thyroid Disorders, Adrenal Gland Disorders, Pituitary Gland Disorders, Parathyroid Disorders, Other Endocrine Conditions_x000D_

6) By Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Polyps, Gastric Ulcers, Liver Cirrhosis, Pancreatic Disorders, Hepatitis, Other Gastrointestinal Conditions_x000D_

7) By Other Target Therapeutic Areas: Musculoskeletal Disorders, Renal Disorders, Pulmonary Disorders, Hematologic Disorders, Dermatological Disorders, Infectious Diseases, Other Miscellaneous Conditions_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=24424&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Virtual Biopsy Market Growth?#_x000D_

North America was the largest region in the virtual biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Key Market Trends and Innovations Are Shaping the Future of the Virtual Biopsy Industry?#_x000D_

Leading firms in the virtual biopsy market are concentrating on the production of technologically superior solutions and securing approvals like the magnetic resonance spectroscopy (MRS) platform. Their aim is to bolster non-intrusive diagnostic precision and offer real-time analysis for the early detection of diseases and tailored treatment options. Magnetic resonance spectroscopy (MRS), a non-intrusive imaging method that aids virtual biopsy, delivers comprehensive molecular data of tissues. This enables precise, instantaneous disease detection and tracking, eliminating the need for invasive approaches. For example, in November 2023, BrainSpec Inc., a healthtech enterprise based in the US, obtained U.S. Food and Drug Administration (FDA) authorization for its artificial intelligence (AI)-powered BrainSpec platform. This cutting-edge technology uses enhanced AI to parse MR spectroscopy data to measure brain metabolites like 2-hydroxyglutarate, aiding non-intrusive virtual biopsies for the diagnosis of ailments such as gliomas, Alzheimer’s, and multiple sclerosis. The system, which integrates smoothly with standard magnetic resonance imaging (MRI) scanners, automates data processing and delivers results within minutes. Additionally, it employs a reference database of brain chemistry to enhance diagnostic precision._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/virtual-biopsy-global-market-report_x000D_

_x000D_

#How Is the Virtual Biopsy Market Defined and What Are Its Core Parameters?#_x000D_

Virtual biopsy is a non-invasive diagnostic technique that uses advanced imaging technologies combined with computer algorithms to analyze tissues for signs of disease. Its primary purpose is to detect abnormalities, such as tumors or infections, without the need for a traditional tissue sample, reducing risks and recovery time for patients. This method is safer, faster, and less painful than traditional biopsies._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24424_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model